Point72 (DIFC)’s Fennec Pharmaceuticals FENC Stock Holding History

Point72 (DIFC)’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-256	Closed	-$2.85K	–	1596
2024 Q1	$2.85K	Buy	+256	New	+$2.57K	﹤0.01%	1389

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Point72 (DIFC)'s FENC Position: Q2 2024 in Review

Point72 (DIFC) sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 256 shares — an estimated $2.85K sold.

Point72 (DIFC) first reported a position in FENC in Q1 2024 and held it in 1 quarter. The position peaked at $2.85K in Q1 2024. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.

Point72 (DIFC) reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Point72 (DIFC) sold 256 Fennec Pharmaceuticals shares in Q2 2024, an estimated $2.85K.
Point72 (DIFC) first reported a position in Fennec Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Point72 (DIFC)'s Fennec Pharmaceuticals position peaked at $2.85K in Q1 2024.
64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.

Based on Point72 (DIFC)'s 13F filing for Q2 2024, filed 14 Aug 2024.